Baslaim Muna M, Junainah Enaam M, Ahmad Hadeel H, Semilan Anmar F, Al-Ghamdi Ahmed O, Rahimuddin Noora O, Salman Budoor A
Department of Surgery, Breast Unit, King Fahd General Hospital, Jeddah, Saudi Arabia.
Breast Pathology, Breast Unit, King Fahd General Hospital, Jeddah, Saudi Arabia.
Int J Surg Case Rep. 2017;33:92-96. doi: 10.1016/j.ijscr.2017.02.044. Epub 2017 Feb 27.
Glycogen Rich Clear Cell Carcinoma (GRCC) is a rare variant of breast carcinomas and believed to be linked with a poor prognosis.
We are presenting a 60-year-old Saudi lady with a 2cm GRCC carcinoma associated with clear cell ductal carcinoma in situ (DCIS) and no axillary lymph node involvement. The tumor was Estrogen and Progesterone receptors (ER & PR) positive and HER 2-neu negative. She underwent mastectomy with sentinel lymph node biopsy followed by hormonal therapy. She is alive and free of disease for 35 months.
The prognosis of GRCC may not be different from other types of invasive breast cancer.
富含糖原的透明细胞癌(GRCC)是乳腺癌的一种罕见变体,被认为与预后不良有关。
我们报告一位60岁的沙特女性,患有2厘米的GRCC癌,伴有原位透明细胞导管癌(DCIS),且无腋窝淋巴结受累。肿瘤雌激素和孕激素受体(ER & PR)阳性,HER 2- neu阴性。她接受了乳房切除术及前哨淋巴结活检,随后进行了激素治疗。她存活且无疾病状态达35个月。
GRCC的预后可能与其他类型的浸润性乳腺癌无异。